Charles River Laboratories International Inc (NYSE:CRL)

145.81
Delayed Data
As of Mar 19
 +0.91 / +0.63%
Today’s Change
101.58
Today|||52-Week Range
146.31
+28.83%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 151.00, with a high estimate of 165.00 and a low estimate of 110.00. The median estimate represents a +3.56% increase from the last price of 145.81.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Charles River Laboratories International Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.40
Sales
$601.2M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.32%
 
 
 
 
 
 
Growthannually 6.46%
 
 
 
 
 
 

Sales

Growthquarterly -0.06%
 
 
 
 
 
 
Growthannually 14.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.